Multiply Labs raised a $75M Series B to scale robotic drug manufacturing. The company builds robots that automate laboratory work used to produce gene therapies and mRNA treatments. Drugmakers purchase and operate the machines at their own facilities, with Multiply also selling cartridges, service, and support. Deployments are in the high single digits.
- Company
- Multiply Labs multiplylabs.com
- Round
- Series B
- Amount
- $75M
- Source
- businessinsider.com
- In the newsletter
- No. 301, Toast for Factories
No. 305, Let’s Livestream Factories